1
|
Dominietto A, Vagge S, di Grazia C, Bregante S, Raiola AM, Varaldo R, Gualandi F, Gusinu M, Barra S, Agostinelli S, Angelucci E, Hui S. Total marrow irradiation for second allogeneic hematopoietic stem cell transplantation in patients with advanced acute leukemia. Transplant Cell Ther 2023:S2666-6367(23)01246-0. [PMID: 37094701 DOI: 10.1016/j.jtct.2023.04.014] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/14/2022] [Revised: 04/07/2023] [Accepted: 04/17/2023] [Indexed: 04/26/2023]
Abstract
BACKGROUND Second allogeneic hematopoietic stem cell transplantation (HSCT) is a treatment option for patients with acute leukemia relapsing after a first HSCT. While a myeloablative (MA) conditioning regimen before the first HSCT is considered better than reduced intensity (RIC) in terms of disease control in acute leukemia patients, the optimal conditioning regimen for the second allogeneic HSCT remains controversial. The most important prognostic factors are the remission disease phase at the time of the second HSCT and more than 12 months from the first to the second HSCT. Total Marrow Irradiation (TMI) is an advanced high-precision radiation treatment that delivers therapeutic doses over extensively selected targets while substantially reducing radiation to vital organs compared to conventional Total Body Irradiation (TBI). Herein we report the results of a retrospective analysis on second allogeneic transplantation treated with TMI as a myeloablative conditioning regimen, intending to limit toxicity. OBJECTIVE We investigated the efficacy of a high dose per fraction TMI in combination with thiotepa, fludarabine and melphalan in 13 consecutive patients with acute leukemia relapsed after a first allogeneic HSCT treated between March 2018 and November 2021. STUDY DESIGN Donor type was haploidentical (HAPLO, n=10), unrelated (UD n=2), and HLA-identical sibling (SIB, n=1). The conditioning regimen consisted of TMI 8 Gy in 5 patients on day -8 -7 or TMI 12 Gy in 8 patients on day -9 -8 -7, plus Thiotepa 5 mg/Kg on day -6, Fludarabine 50 mg/mq on day -5 -4 -3, Melphalan 140 mg/mq on day -2. TMI was delivered in a hypofractionated daily single dose of 4 Gy for three consecutive fractions. The median age was 45 years (range, 19-70 years); 7 patients were in remission, and 6 had active disease at the time of the second allogeneic HSCT. RESULTS The median time to neutrophil counts of > 0.5×10e9/L was 16 days (range 13-22), and platelet counts of > 20×10e9/L were 20 days (range 14-34), respectively. All patients showed a complete donor chimerism on day 30 after the transplant. The cumulative incidence of grade I II acute GvHD (aGvHD) was 43%, and chronic GvHD (cGVHD) was 30%. The median follow-up was 1121 days (range 200-1540). Day +30 and +100 transplant-related mortality (TRM) was 0. Overall cumulative incidence of TRM, relapse rate, and disease free-survival (DFS) were respectively 27%,7%, and 67%. CONCLUSIONS This retrospective study showed the safety and efficacy of a hypofractionated TMI conditioning regimen in patients with acute leukemia receiving second HSCT with encouraging outcomes regarding engraftment, early toxicity, GvHD, and relapse.
Collapse
Affiliation(s)
- A Dominietto
- U.O. Ematologia e Terapie Cellulari, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
| | - S Vagge
- Department of Radiation Oncology, Galliera Hospital, Genoa, Italy
| | - C di Grazia
- U.O. Ematologia e Terapie Cellulari, IRCCS Ospedale Policlinico San Martino, Genoa, Italy
| | - S Bregante
- U.O. Ematologia e Terapie Cellulari, IRCCS Ospedale Policlinico San Martino, Genoa, Italy
| | - A M Raiola
- U.O. Ematologia e Terapie Cellulari, IRCCS Ospedale Policlinico San Martino, Genoa, Italy
| | - R Varaldo
- U.O. Ematologia e Terapie Cellulari, IRCCS Ospedale Policlinico San Martino, Genoa, Italy
| | - F Gualandi
- U.O. Ematologia e Terapie Cellulari, IRCCS Ospedale Policlinico San Martino, Genoa, Italy
| | - M Gusinu
- Department of Medical Physics, IRCCS Ospedale Policlinico San Martino, Genoa, Italy
| | - S Barra
- Department of Radiation Oncology, IRCCS Ospedale Policlinico San Martino, Genoa, Italy
| | - S Agostinelli
- Department of Medical Physics, IRCCS Ospedale Policlinico San Martino, Genoa, Italy
| | - E Angelucci
- U.O. Ematologia e Terapie Cellulari, IRCCS Ospedale Policlinico San Martino, Genoa, Italy
| | - S Hui
- Department of Radiation Oncology, Beckman Research Institute, City of Hope National Medical Center, Duarte, CA 91010 USA
| |
Collapse
|
2
|
Franco P, Porreca A, Di Nicola M, Mantello G, Valvo F, Slim N, Manfrida S, Gambacorta M, De Felice F, Vagge S, Krengli M, Palazzari E, Osti M, Gonelli A, Catalano G, Pittoni P, Lupattelli M, Niespolo M, Rosetto M, Macchia G, Durante O, Munoz F, D'Angelillo R, Genovesi D, Caravatta L. OC-0272 External validation of the Hemo-Eosinophils-Inflammation index as a prognosticator in anal cancer. Radiother Oncol 2022. [DOI: 10.1016/s0167-8140(22)02530-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
3
|
Gusinu M, Zefiro D, Vagge S, Di Palermo R, Cavagnetto F, Corvò R, Levrero F. First experience of single-fraction lung SBRT with Radixact synchrony tracking method: preliminary comparison of dose distribution with radiochromic film dosimetry. Phys Med 2021. [DOI: 10.1016/s1120-1797(22)00351-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/28/2022] Open
|
4
|
Vagge S, Esposito D, Tramontano D, Corvò R, Angelucci E, Dominietto A. PO-1076 Hypofractionated Total Marrow Irradiation in second allogeneic hematopoietic stem cell transplantats. Radiother Oncol 2021. [DOI: 10.1016/s0167-8140(21)07527-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
5
|
Vagge S, Guolo F, Ballerini F, Agostinelli S, Tramontano D, Chiola I, Olivetta E, Corvò R, Angelucci E, Lemoli R. PO-0911: Volumetric total lymphoid hypofractionated irradiation and stem cell transplantation in lymphomas. Radiother Oncol 2020. [DOI: 10.1016/s0167-8140(21)00928-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
6
|
Vagge S, Guolo F, Dominietto A, Agostinelli S, Gusinu M, Ibatici A, Ballerini F, Lemoli R, Angelucci E, Gobbi M, Corvò R. PV-0366 Helical Total Lymphoid Irradiation: radiotherapy still works in lymphoma transplantation. Radiother Oncol 2019. [DOI: 10.1016/s0167-8140(19)30786-8] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
7
|
Levrero F, Daga A, Ravetti J, Corv‘o R, Fella M, Marcello D, Marubbi D, Mussap M, Neumaier C, Profumo A, Raso A, Rosa F, Vagge S, Vecchio D, Frosina G. 224. Irradiation of glioma initiating cells-driven orthotopic glioblastoma after delivering of ATM inhibitor KU60019 as a radiosensitizer. Phys Med 2018. [DOI: 10.1016/j.ejmp.2018.04.235] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/27/2022] Open
|
8
|
Vaccara E, Gho A, Belgioia L, Vagge S, Marcenaro M, Corvò R, Levrero F. 147. Setup accuracy in Lung Stereotactic Body Radiation Therapy (SBRT): Single lesion versus multiple lesions. Phys Med 2018. [DOI: 10.1016/j.ejmp.2018.04.158] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/27/2022] Open
|
9
|
Engels B, De Paoli A, Delmastro E, Munoz F, Vagge S, Norkus D, Everaert H, Tabaro G, Garibaldi E, Ricardi U, Borsatti E, Gabriele P, Boz G, Dubaere E, Mahe M, Gevaert T, De Ridder M. Preoperative Radiation Therapy with a Simultaneous Integrated Boost Compared to Chemoradiotherapy for cT3-4 Rectal Cancer: A Multicentric Randomized Study. Int J Radiat Oncol Biol Phys 2018. [DOI: 10.1016/j.ijrobp.2018.06.178] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
10
|
Bruni A, Grossi F, Katia F, Capelletto E, Buffoni L, Badellino S, Poletti V, Chiari R, Giaj Levra N, Banna G, Vagge S, Borghetti P, Baldini E, Bria E, Tiseo M, Paci M, Ciammella P, Taraborrelli M, Ricardi U, Scotti V. The standard of care for stage III NSCLC in the era of immunotherapy: An Italian national survey on the current pattern of care among Italian thoracic oncologists. Ann Oncol 2018. [DOI: 10.1093/annonc/mdy291.013] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
11
|
Belgioia L, Bacigalupo A, Chiola I, Blandino G, Lamanna G, Vagge S, Scabini S, Romairone E, Murialdo R, Ballestrero A, Corvò R. EP-1305: Impact of time from neoadjuvant treatment and surgery in rectal cancer: a monoinstitutional report. Radiother Oncol 2016. [DOI: 10.1016/s0167-8140(16)32555-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
12
|
Vagge S, Marcenaro M, Timon G, Siffredi G, Corvò R. EP-1255: SABR and FDG-PET in lung cancer: a SUV cut-off value before treatment to predict local control. Radiother Oncol 2016. [DOI: 10.1016/s0167-8140(16)32505-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
13
|
De Ridder M, De Paoli A, Delmastro E, Munoz F, Vagge S, Norkus D, Everaert H, Tabaro G, Garibaldi E, Ricardi U, Borsatti E, Gevaert T, Gabriele P, Boz G, Sermeus A, Mahé M, Engels B. OC-0145: Preoperative radiotherapy with an integrated boost compared to chemoradiotherapy for rectal cancer. Radiother Oncol 2016. [DOI: 10.1016/s0167-8140(16)31394-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
14
|
Belgioia L, Vagge S, Agnese A, Garelli S, Murialdo R, Fornarini G, Chiara S, Bacigalupo A, Corvò R. EP-1208: Accelerated Intensity Modulated Radiotherapy with SIB in anal cancer: outcomes of a retrospective trial. Radiother Oncol 2015. [DOI: 10.1016/s0167-8140(15)41200-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
15
|
Vagge S, Lamanna G, Vidano G, Ibatici A, Agostinelli S, Carella A, Corvò R. PO-0804: Volumetric Total Lymphoid Irradiation: step-up an effective treatment for stem cell transplantation in lymphoma. Radiother Oncol 2015. [DOI: 10.1016/s0167-8140(15)40796-0] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
16
|
Bacigalupo A, Belgioia L, Vecchio S, Marcenaro M, Vagge S, Agnese D, Agostinelli S, Corvò R. PO-060: Long term results with intensified intensity modulated radiotherapy for nasopharyngeal cancer treatment. Radiother Oncol 2015. [DOI: 10.1016/s0167-8140(15)34820-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
17
|
Engels B, De Paoli A, Cattari G, Munoz F, Vagge S, Norkus D, Gabriele P, Tabaro G, Versmessen H, De Ridder M. Preoperative Radiotherapy with a Simultaneous Integrated Boost Compared to Chemoradiation therapy for T3-4 Rectal Cancer: Interim Analysis of a Multicentric Randomized Trial. Int J Radiat Oncol Biol Phys 2014. [DOI: 10.1016/j.ijrobp.2014.05.117] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
|
18
|
Blandino G, Timon G, Vidano G, Verzanini E, Vagge S, Marcenaro M, Barra S, Corvò R. EP-1279: Evauation of biochemical response in relation to RT schedule for prostate cancer: Preliminary experience. Radiother Oncol 2014. [DOI: 10.1016/s0167-8140(15)31397-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
19
|
Marcenaro M, Agnese D, Belgioia L, Lamanna G, Aloi D, Vagge S, Garelli S, Gusinu M, Cavagnetto F, Corvò R. EP-1035: Stereotactic body irradiation (SBRT) in patients with exclusive CTPET-based diagnosis of lung malignancies. Radiother Oncol 2013. [DOI: 10.1016/s0167-8140(15)33341-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
20
|
Garelli S, Raso R, Scalco E, Vagge S, Bacigalupo A, Salvetti C, Passoni P, Broggi S, Rizzo G, Fiorino C. EP-1257: Rectal motion during radio-chemotherapy of rectal cancer assessed by daily MVCTs and 3D local shift measurements. Radiother Oncol 2013. [DOI: 10.1016/s0167-8140(15)33563-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
21
|
Timon G, Bacigalupo A, Vagge S, Belgioia L, Garelli S, Corvò R. PO-0699: IMRT with SIB in the treatment of anal cancer: a mono-institutional experience. Radiother Oncol 2013. [DOI: 10.1016/s0167-8140(15)33005-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
22
|
Barra S, Marcenaro M, Puppo P, Introini C, Naselli A, Vagge S, Agnese D, Cavagnetto F, Agostinelli S, Corvò R. PO-0993: Intra-operative radiotherapy for prostate cancer: preliminary midterm results of a mono institutional study. Radiother Oncol 2013. [DOI: 10.1016/s0167-8140(15)33299-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
23
|
Lamanna G, Vagge S, Vidano G, Bosetti D, Blandino G, Siffredi G, Milanese M, Corvò R. PO-0743: Once weekly stereotactic radiotherapy for oligometastatic patients: compliance and preliminary efficacy. Radiother Oncol 2013. [DOI: 10.1016/s0167-8140(15)33049-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
24
|
Vagge S, Zeverino M, Parodi L, Pasini A, Costa E, Pupillo F, Corvò R. PO-0923: Patientsí set-up and dose delivery verification for total marrow or lymphoid irradiation with helical Tomotherapy. Radiother Oncol 2013. [DOI: 10.1016/s0167-8140(15)33229-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
25
|
Belgioia L, Timon G, Bacigalupo A, Vagge S, Pupillo F, Marcenaro M, Vecchio S, Corvò R. PO-056: Early-Outcome and Toxicity of RT/CT in the Management of Unknown HN Primary Site with Helical Tomotherapy. Radiother Oncol 2013. [DOI: 10.1016/s0167-8140(15)34675-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
26
|
Bacigalupo A, Timon G, Vagge S, Belgioia L, Bellini A, Marcenaro M, Vecchio S, Corvò R. PO-057: SIB-IMRT Delivered By Helical Tomotherapy for Patients with Nasopharyngeal Carcinoma. Radiother Oncol 2013. [DOI: 10.1016/s0167-8140(15)34676-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
27
|
Lamanna G, Vagge S, Parodi L, Taccini G, Corvò R. OC-0391 EVALUATION OF CT ATLAS-BASED SEGMENTATION OF WHOLE BODYÍS ORGANS FOR LARGE FIELDS IRRADIATION. Radiother Oncol 2012. [DOI: 10.1016/s0167-8140(12)70730-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
28
|
Bacigalupo A, Marcenaro M, Vagge S, Timon G, Torielli P, Vecchio S, Cavagnetto F, Gusinu M, Corvò R. EP-1162 DOSE DISTRIBUTION AND COMPLIANCE IN NPC TREATED BY TOMOTHERAPY COMBINED WITH CT: A MONO-INSTITUTIONAL EXPERIENCE. Radiother Oncol 2012. [DOI: 10.1016/s0167-8140(12)71495-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
|
29
|
Pupillo F, Zeverino M, Vagge S, Agostinelli S, Corvò R, Taccini G. PO-0831 PRELIMINARY RESULTS FROM IN VIVO DOSIMETRY PERFORMED WITH HELICAL TOMOTHERAPY-BASED TMI/TLI TREATMENTS. Radiother Oncol 2012. [DOI: 10.1016/s0167-8140(12)71164-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
30
|
Vagge S, Zeverino M, Vidano V, Fozza A, Barra S, Taccini G, Pica G, Carella A. EP-1037 FEASIBILITY OF TOTAL LYMPHOID IRRADIATION WITH HELICAL TOMOTHERAPY IN MALIGNANT LYMPHOMAS BEFORE AUTOGRAFT. Radiother Oncol 2012. [DOI: 10.1016/s0167-8140(12)71370-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
31
|
Vagge S, Zeverino M, Agostinelli S, Barra S, Frassoni F, Taccini G, Bacigalupo A, Corvò R. 909 poster TOTAL MARROW IRRADIATION AS SELECTIVE BOOST MODALITY AFTER CONVENTIONAL TBI FOR PATIENTS WITH ADVANCED HEMOPOIETIC MALIGNANCIES UNDERGOING AN ALLOGENEIC STEM CELL TRANSPLANT. Radiother Oncol 2011. [DOI: 10.1016/s0167-8140(11)71031-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
32
|
Marcenaro M, Belgioia L, Mantero E, Doino D, Agnese D, Vagge S, Agostinelli S, Cavagnetto F, Garelli S, Gusinu M, Zeverino M, Corvò R. 898 poster STEREOTACTIC BODY IRRADIATION WITH HELICAL TOMOTHERAPY FOR T1-T2 NSCLC OR LUNG METASTASES FROM OTHER PRIMARY SITES. Radiother Oncol 2011. [DOI: 10.1016/s0167-8140(11)71020-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
33
|
Bacigalupo A, Vagge S, Bosetti D, Vidano G, Gusinu M, Agostinelli S, Marcenaro M, Vecchio S, Zeverino M, Corvò R. PRELIMINARY EXPERIENCE WITH HELICAL TOMOTHERAPY USING SIMULTANEOUS INTEGRATED BOOST (SIB) IN NASOPHARYNX CANCER. Radiother Oncol 2011. [DOI: 10.1016/s0167-8140(11)70079-2] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
34
|
Vagge S, Bacigalupo A, Marcenaro M, Agostinelli S, Zeverino M, Corvò R. LOCALLY ADVANCED NASOPHARYNGEAL CARCINOMA: A COMPARISON, BETWEEN HELICAL TOMOTHERAPY AND STEP & SHOOT IMRT, TOWARDS THE NEW CONTOURING BOUNDARIES. Radiother Oncol 2011. [DOI: 10.1016/s0167-8140(11)70105-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
35
|
Zeverino M, Agostinelli S, Taccini G, Cavagnetto F, Garelli S, Gusinu M, Vagge S, Barra S, Corvò R. Total Marrow Irradiation with Helical Tomotherapy Along the Entire Patient's Axis: A Planning Technique to Merge Helical Dose Distributions Producing Uniform Dose in the Junction Region. Int J Radiat Oncol Biol Phys 2010. [DOI: 10.1016/j.ijrobp.2010.07.1902] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|